Persistence Pays Off for Praxis as Essential Tremor Drug Succeeds in Two Pivotal Studies
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended ...
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended ...
Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment ...
Pfizer is the first big pharmaceutical company to reach an agreement with the Trump administration over most-favored nation drug pricing, ...
Genmab’s growth and pipeline diversification strategy is picking up another piece through the acquisition of Merus in an $8 billion ...
Patients who have a particular genetic disease whose symptoms include progressively worsening muscle control were able to walk faster following ...
There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio ...
The latest headlines from our reporters across the US sent straight to your inbox each weekdayYour briefing on the latest ...
The target of AllRock Bio’s research is already validated by FDA-approved medicines — for the eyes. The biotech startup is ...
An experimental Maze Therapeutics drug increased urinary excretion of compounds that are biological indicators of metabolic disease, early clinical trial ...
While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as ...
Copyright © 2024 The Israel Chronicle News.
The Israel Chronicle News is not responsible for the content of external sites.